更年平脉汤联合缬沙坦治疗冲任失调型围绝经期高血压临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R544.1

基金项目:

国家自然科学基金面上项目(81774111);上海中医药大学产业发展中心医养结合科创项目(YYKC-2021-01-157)


Clinical Study on Gengnian Pingmai Decoction Combined with Valsartan for Hyperten⁃ sion of Disharmony of the Chong and Ren Mai Type in Perimenopausal Period
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察更年平脉汤联合缬沙坦治疗冲任失调型围绝经期高血压的临床疗效。方法:选取 120 例冲任失调型围绝经期高血压患者,采用随机数字表法分为观察组和对照组,每组60 例,对照组剔除 2 例,观察组剔除1 例,最终纳入研究对照组58 例,观察组59 例。观察组给予更年平脉汤联合缬沙坦治疗, 对照组仅予以缬沙坦治疗,2 组均治疗12 周。评估2 组临床疗效,比较2 组治疗前后中医证候积分,促卵泡 刺激素(FSH)、促黄体生成素(LH)、雌二醇(E2)、总胆固醇(TC)、低密度脂蛋白(LDL)、甘油三 酯(TG) 水平, 以及24 h 平均收缩压(24 hSBP)、24 h 平均舒张压(24 hDBP)、24 h 收缩压变异系 数(24 hSBPcv)、24 h 舒张压变异系数(24 hDBPcv)。结果:治疗后,观察组临床疗效总有效率91.53%,高 于对照组67.24%(P<0.05)。治疗后,2 组中医证候积分均较治疗前降低(P<0.05),观察组中医证候积分低 于对照组(P<0.05)。治疗后,2 组24 hSBP、24 hDBP、24 hSBPcv 均较治疗前降低(P<0.05),观察组 24 hDBPcv 较治疗前降低(P<0.05),对照组24 hDBPcv 与治疗前比较,差异无统计学意义(P>0.05);观察 组24 hSBP、24 hDBP、24 hSBPcv、24 hDBPcv 均低于对照组(P<0.05)。治疗后,观察组血清FSH 及LH 水 平均较治疗前降低,且均低于对照组(P<0.05);观察组血清E2 水平较治疗前升高,且高于对照组(P< 0.05)。对照组治疗前后血清FSH、LH、E2 水平比较,差异均无统计学意义(P>0.05)。治疗后,2 组TG 水平 均较治疗前降低(P<0.05),观察组TG 水平低于对照组(P<0.05);观察组TC、LDL 水平均较治疗前降低, 且均低于对照组(P<0.05)。对照组治疗前后TC、LDL 水平比较,差异均无统计学意义(P>0.05)。结论: 在缬沙坦基础上使用更年平脉汤治疗可以降低冲任失调型围绝经期高血压患者的平均血压,缓解围绝经期症 状,调节雌激素及脂代谢水平。

    Abstract:

    Abstract: Objective: To observe the clinical effect of Gengnian Pingmai Decoction combined with Valsartan for hypertension of disharmony of the chong and ren mai type in perimenopausal period. Methods:A total of 120 cases of patients with hypertension of disharmony of the chong and ren mai type in perimenopausal period were selected and divided into the observation group and the control group according to the random number table method, with 60 cases in each group. Two cases in the control group and one case in the observation group were excluded. Finally,58 cases in the control group and 59 cases in the observation group were included. The observation group was treated with Gengnian Pingmai Decoction combined with Valsartan,and the control group was simply treated with Valsartan. Both groups were treated for 12 weeks. The clinical effects in the two groups were evaluated. Before and after treatment, the traditional Chinese medicine (TCM) syndrome scores, the levels of follicle stimulating hormone (FSH), luteinizing hormone (LH), estrogen (E2), total cholesterol (TC), low density lipoprotein (LDL), and triglyceride (TG), 24- hour mean systolic blood pressure (24 hSBP), 24- hour mean diastolic blood pressure (24 hDBP), 24- hour systolic blood pressure coefficient of variation (24 hSBPcv), and 24- hour diastolic blood pressure coefficient of variation (24 hDBPcv) were compared between the two groups. Results: After treatment, the total clinical effective rate was 91.53% in the observation group, higher than that of 67.24% in the control group (P<0.05). After treatment,TCM syndrome scores in the two groups were decreased when compared with those before treatment (P<0.05), and the TCM syndrome score in the observation group was lower than that in the control group (P<0.05). After treatment, 24 hSBP, 24 hDBP and 24 hSBPcv in the two groups were decreased when compared with those before treatment (P<0.05), the 24 hDBPcv in the observation group was lower than that before treatment (P<0.05),and there was no significant difference being found in the comparison of 24 hDBPcv in the control group before and after treatment (P>0.05);24 hSBP,24 hDBP,24 hSBPcv,24 hDBPcv in the observation group were lower than those in the control group (P<0.05). After treatment,the levels of FSH and LH in serum in the observation group were decreased when compared with those before treatment,and were lower than those in the control group (P<0.05);E2 level in serum in the observation group was increased when compared with that before treatment,and was higher than that in the control group (P<0.05). Before and after treatment, there was no significant difference being found in the comparison of levels of FSH,LH and E2 in serum in the control group (P>0.05). After treatment,TG levels in the two groups were decreased when compared with those before treatment (P<0.05),and TG level in the observation group was lower than that in the control group (P<0.05);the levels of TC and LDL in the observation group were decreased when compared with those before treatment and were lower than those in the control group (P<0.05). There was no significant difference being found in the comparison of levels of TC and LDL in the control group before and after treatment (P>0.05). Conclusion: On the basis of Valsartan,the treatment of Gengnian Pingmai Decoction can reduce the average blood pressure of patients with hypertension of disharmony of the chong and ren mai type in perimenopausal period, relieve perimenopausal symptoms,and regulate the levels of estrogen and lipid metabolism.

    参考文献
    相似文献
    引证文献
引用本文

王一帆,桂明泰,符德玉.更年平脉汤联合缬沙坦治疗冲任失调型围绝经期高血压临床研究[J].新中医,2023,55(10):75-80

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-05-25
  • 出版日期:
文章二维码